Your browser is unable to support new features implemented in HTML5 and CSS3 to render this site as intended. Your experience may suffer from functionality degradation but the site should remain usable. We strongly recommend the latest version of Google Chrome, OS X Safari or Mozilla Firefox. As Safari is bundled with OS X, if you are unable to upgrade to a newer version of OS X, we recommend using an open source browser. Dismiss message

IPR042946

Description

IPR042946 is a Carboxymethylenebutenolidase homolog.

<p>Carboxymethylenebutenolidase (CMBL) is a human homologue of Pseudomonas dienelactone hydrolase involved in the bacterial halocatechol degradation pathway. It is a cysteine hydrolase that can convert the prodrug olmesartan medoxomil into its pharmacologically active metabolite olmerstatan, an angiotensin receptor blocker, in liver and intestine [[cite:PUB00093512]].</p> <p>This entry also includes uncharacterised DLH domain-containing proteins from plants.</p>

This description is obtained from EB-eye REST.

Associated GO terms

Unable to find any GO terms for the transcript with the identifier.

Associated Lotus transcripts 1

Transcript Name Description Predicted domains Domain count
1,4-beta-D-glucanase; TAIR: AT1G35420.2 alpha/beta-Hydrolases superfamily protein; Swiss-Prot: sp|Q96DG6|CMBL_HUMAN Carboxymethylenebutenolidase homolog; TrEMBL-Plants: tr|I1KFZ9|I1KFZ9_SOYBN Uncharacterized protein; Found in the gene: LotjaGi3g1v0337900 7

Co-occuring domains 1

A list of co-occurring predicted domains within the L. japonicus gene space:

Predicted domain Source Observations Saturation (%)
SSF53474 SUPERFAMILY 1 100.00